Calumet Spec. Prods Part. ADR

Calumet reported Q1 2026 earnings per share of -$3.64, missing analysts’ expectation of -$0.31, while revenue of $1.03 billion slightly exceeded estimates. A production outage in Shreveport due to organic chloride contamination cost about 750,000 barrels and roughly $30 million, which pushed adjusted EBITDA down to $50.1 million. Montana Renewables showed strong operational improvements (adjusted EBITDA +209%) and the MaxSAF-150 expansion began operations, while the new SET-2 RVO has significantly increased demand for biofuels and improved margins. Management expects that the resumption of production and a better market environment will lead to improved results in 2026, but continues to see challenges with the debt structure. » More on de.investing.com

Calumet expects to release results for the quarter ended 31 March 2026 on 8 May 2026. Five analysts on average expect earnings per share of -$0.333 versus -$1.870 in the year‑ago quarter. Six analysts forecast revenue of around $1.01 billion (+1.93% year‑on‑year). For the current fiscal year the consensus estimate is $0.077 per share and revenue of about $4.41 billion. » More on finanzen.net

Jennifer Straumins will not stand for re-election to Calumet’s supervisory board at the annual general meeting in 2026 and will leave the board at the end of her term. Straumins has been a member of the supervisory board since July 2024; she was previously a member of the board of Calumet GP, LLC and worked for the company for 13 years. She currently serves on the strategy and growth committee and the risk committee; the supervisory board now intends to review the composition and competencies of the body. » More on de.investing.com